Intensity Therapeutics Company Insiders
| INTS Stock | 0.42 0.01 2.33% |
Intensity Therapeutics employs about 5 people. The company is managed by 3 executives with a total tenure of roughly 12 years, averaging almost 4.0 years of service per executive, having 1.67 employees per reported executive. Breaking down Intensity Therapeutics' management performance can provide insight into the firm performance.
Intensity | Build AI portfolio with Intensity Stock |
Intensity Therapeutics Management Team Effectiveness
The company has return on total asset (ROA) of (1.0166) % which means that it has lost $1.0166 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (2.347) %, meaning that it created substantial loss on money invested by shareholders. Intensity Therapeutics' management efficiency ratios could be used to measure how well Intensity Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities.Intensity Therapeutics Common has a total of 60.06 Million outstanding shares. Intensity Therapeutics retains 8.77 (percent) of its outstanding shares held by insiders and 7.01 (percent) owned by outside corporations. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in stocks such as Intensity Therapeutics in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Intensity Therapeutics, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Intensity Therapeutics Workforce Comparison
Intensity Therapeutics Common is rated below average in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 365. Intensity Therapeutics claims roughly 5.0 in number of employees contributing just under 2% to equities under Health Care industry.
Intensity Therapeutics Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Intensity Therapeutics insiders, such as employees or executives, is commonly permitted as long as it does not rely on Intensity Therapeutics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Intensity Therapeutics insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Intensity Therapeutics Notable Stakeholders
An Intensity Therapeutics stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Intensity Therapeutics often face trade-offs trying to please all of them. Intensity Therapeutics' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Intensity Therapeutics' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| MA MBA | President Founder | Profile | |
| James Ahlers | Executive Finance | Profile | |
| Brian MD | Executive Development | Profile |
About Intensity Therapeutics Management Performance
The success or failure of an entity such as Intensity Therapeutics often depends on how effective the management is. Intensity Therapeutics management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Intensity management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Intensity management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Please note, the imprecision that can be found in Intensity Therapeutics' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Intensity Therapeutics Common. Check Intensity Therapeutics' Beneish M Score to see the likelihood of Intensity Therapeutics' management manipulating its earnings.
Intensity Therapeutics Workforce Analysis
Traditionally, organizations such as Intensity Therapeutics use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Intensity Therapeutics within its industry.Intensity Therapeutics Manpower Efficiency
Return on Intensity Therapeutics Manpower
| Revenue Per Employee | 0.0 | |
| Revenue Per Executive | 0.0 | |
| Net Loss Per Employee | 3.3M | |
| Net Loss Per Executive | 5.4M | |
| Working Capital Per Employee | 321.6K | |
| Working Capital Per Executive | 536K |
Additional Tools for Intensity Stock Analysis
When running Intensity Therapeutics' price analysis, check to measure Intensity Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intensity Therapeutics is operating at the current time. Most of Intensity Therapeutics' value examination focuses on studying past and present price action to predict the probability of Intensity Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intensity Therapeutics' price. Additionally, you may evaluate how the addition of Intensity Therapeutics to your portfolios can decrease your overall portfolio volatility.